Keep up to date with who we are, where we will be and how we are embracing the future here.
We are pleased to announce today, the launch of our new social media insight and analytics business, Cello Health Logic. The business, born out of Cello Health Insight’s dedicated digital division, aims to meet the need for pharmaceutical and healthcare clients to tap into and better understand the huge volume of real-world conversational data that […]More +
Cello Health are pleased to announce our presence BIO-Europe’s Spring event on March 12–14 in Amsterdam. Stop by booth #14 to speak to one of our team about our capabilities and experience in supporting BioPharm clients from asset identification or acquisition through to informing the Phase 3 programme. In addition to our booth presence, Cello Health […]More +
Cello Health Insight is very pleased to announce that it has been named one of the Best Companies to Work for in New York State for 2018, for the third consecutive year. “We are so delighted to be awarded this honor for the third year in a row. We have always been committed to building […]More +
This February, Cello Health are joining NORD’s Rare Movement Campaign to raise awareness for rare diseases. Together, participants aim to move a total of 7,000 miles of donor-supported movement by Rare Disease Day on February 28th. There are 7,000 known rare diseases, 95% of them have no treatment. Representatives from all of our US businesses […]More +
PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Cello Health Insight’s Experience First as one of the most innovative services of 2017. Experience First is a user experience + design research strategy that focuses on users of a treatment, product and/or service, within […]More +